The United States represents the largest share of the leukapheresis industry in North America, driven by the increasing prevalence of hematologic malignancies, a strong biotechnology sector, and widespread adoption of advanced cell and gene therapies. The country is at the forefront of CAR-T cell therapy development, creating significant demand for leukapheresis procedures used in immune cell collection and processing.

Leukapheresis Market Size and Growth Prospects

The Leukapheresis Market is projected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. This robust growth is attributed to increasing cases of leukemia, lymphoma, and other hematological disorders worldwide. Additionally, the growing use of leukapheresis in research applications and cell therapy manufacturing processes is creating significant growth opportunities for industry participants. Favorable reimbursement policies and increasing healthcare expenditure in emerging economies are further supporting market expansion.

Download Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00005515

Market Trends Shaping Industry Development

Several important trends are influencing the growth trajectory of the industry. The increasing adoption of CAR-T cell therapies and immunotherapies is generating substantial demand for leukapheresis procedures. Biopharmaceutical companies are actively investing in cell and gene therapy development programs, which require high-quality leukocyte collection processes. Another notable trend is the growing preference for disposable apheresis kits that reduce contamination risks and improve patient safety. Additionally, healthcare providers are increasingly focusing on minimally invasive treatment procedures, contributing to wider adoption of leukapheresis technologies.

Growing Burden of Hematological Disorders

The rising incidence of blood-related diseases remains one of the primary growth drivers. According to healthcare organizations worldwide, the number of patients diagnosed with leukemia and lymphoma continues to increase annually. Leukapheresis serves as an essential therapeutic intervention for managing elevated white blood cell counts and supporting advanced treatment protocols. The growing patient pool requiring specialized blood component therapies is creating sustained demand for leukapheresis devices and related services.

Regional Growth Analysis

North America currently dominates the industry due to the presence of advanced healthcare infrastructure, significant investments in research and development, and high adoption rates of innovative treatment technologies. The United States remains a major contributor to regional growth owing to increasing cell therapy clinical trials and strong healthcare spending. Europe also holds a substantial share, supported by favorable regulatory frameworks and growing awareness of advanced blood treatment procedures. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period due to expanding healthcare infrastructure, increasing patient awareness, and rising investments in biotechnology research.

Competitive Landscape and Strategic Developments

Leading companies operating in the industry are focusing on product innovation, strategic partnerships, mergers, acquisitions, and geographic expansion to strengthen their market position. Manufacturers are investing heavily in research and development activities to enhance device performance and improve patient outcomes. Collaborations between healthcare institutions and biotechnology companies are also contributing to industry growth by facilitating the development of next-generation cell therapy solutions.

Key Players

• Asahi Kasei Corporation
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Terumo Corporation
• STEMCELL Technologies Inc.
• HemaCare
• Macopharma
• AllCells
• STEMEXPRESS
• BioIVT

Future Outlook

The future outlook remains highly promising, driven by the increasing demand for cell and gene therapies, advancements in blood separation technologies, and growing investments in precision medicine. The expanding application of leukapheresis in immunotherapy manufacturing and stem cell collection is expected to create lucrative opportunities for market participants. As healthcare systems continue to adopt innovative treatment approaches, the industry is poised for sustained growth throughout the forecast period. Technological advancements, expanding clinical research activities, and increasing awareness regarding hematological disease management will further support long-term industry expansion.

Related Reports

Healthcare Data Monetization Market Growth, Size & Forecast by 2034

Healthcare Nanotechnology (Nanomedicine) Market Growth, Size & Forecast by 2034

About Us

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish